Search results
RFK Jr. will be considered for Libertarian Party’s presidential nomination. Trump didn’t file...
CNN.com· 2 hours agoIndependent presidential candidate Robert F. Kennedy Jr. will be considered for the Libertarian...
Covid will still be here this summer. Will anyone care?
Washington Post via Yahoo News· 51 minutes agoBy now, it’s as familiar as sunscreen hitting the shelves: Americans are headed into another summer...
How Much Will Pfizer Pay Out in Dividends This Year?
Motley Fool via Yahoo Finance· 13 hours agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (NYSE: PFE) a household name in recent years, but this isn't all the company sells. There...
Tufts wins 2024 NCAA DIII men's lacrosse national championship
NCAA· 2 hours agoComplete information for the 2024 NCAA DIII men's lacrosse championship, including the bracket,...
Europa League winners Atalanta bask in hero's welcome on home return
AFP via Yahoo Sports· 2 hours agoAtalanta were given a hero's welcome on Sunday as the Europa League winners strolled past Torino 3-0...
How Much Will Pfizer Pay Out in Dividends This Year? | The Motley Fool
The Motley Fool· 13 hours agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (PFE 0.66%) a household name in recent years, but this isn't all the company sells. There ...
Khabib has made his prediction for Islam Makhachev vs Dustin Poirier at UFC 302
GiveMeSport· 5 hours agoIslam Makhachev will finish UFC 302 opponent Dustin Poirier in three rounds or less when they come...
Trump booed and heckled by raucous crowd at Libertarian convention
Reuters· 33 minutes agoLibertarians, who believe in limited government and individual freedom, blame Trump, a Republican,...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 3 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company ...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 12 hours agoThe past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was...